Identity & Authority: GSK (Zyban) – Signal Evidence & AI Readability

GSK (Zyban)

(https://zyban.com) 📸 Data Snapshot: May 26, 2026
Identity & Authority — The Lens

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Identity & Authority Expert verifiability & Schema depth.
5 Impact Weight: 15 / 100
33% Reputation

A significant authority gap exists due to the total absence of schema_json to verify the domain’s official status or connection to GSK. No experts are named and no Person schema is used to establish medical credibility or digital footprint for the authors. The technical credibility gap is high because an authority-level pharmaceutical domain is currently serving a broken resource message rather than a secure, clinical information environment.

The site makes no performance claims, but the disconnect exists in the absence of expected clinical trial data or mechanism of action descriptions. The site fails to demonstrate any of the proof expectations defined for the pharma industry, such as regulatory clearance numbers. This creates a vacuum where clinical authority should be for a therapeutic brand.

Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.

🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage — no schema detected (entity gap)
🛡️ Trust Signals — external proof links that back the declared identity
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0